These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32862587)

  • 1. Neutrophil-to-lymphocyte ratio: a hidden gem in predicting neoadjuvant treatment response in locally advanced rectal cancer?
    Andras D; Crisan D; Craciun R; Nemes A; Caziuc A; Drasovean R; Seicean R; Scurtu R; Bințințan V; Eniu D; Coman I; Dindelegan G
    J BUON; 2020; 25(3):1436-1442. PubMed ID: 32862587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
    Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
    Duque-Santana V; López-Campos F; Martin-Martin M; Valero M; Zafra-Martín J; Couñago F; Sancho S
    Oncology; 2023; 101(6):349-357. PubMed ID: 36273439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
    BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
    Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    Shen J; Zhu Y; Wu W; Zhang L; Ju H; Fan Y; Zhu Y; Luo J; Liu P; Zhou N; Lu K; Zhang N; Li D; Liu L
    Med Sci Monit; 2017 Jan; 23():315-324. PubMed ID: 28100902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
    Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
    Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
    Liu M; Feng Y; Zhang Y; Liu H
    Biomed Res Int; 2022; 2022():3839670. PubMed ID: 36212713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
    Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z
    Technol Cancer Res Treat; 2023; 22():15330338231202611. PubMed ID: 37807729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-Lymphocyte Ratio (NLR) as a Poor Predictive Biomarker for Pathological Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Study.
    Novin K; Fadavi P; Mortazavi N; Sanei M; Khoshbakht Ahmadi H; Barahman M; Noori R; Hoveidamanesh S; Shahin M; Taghizadeh-Hesary F
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):61-67. PubMed ID: 36708552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
    Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG
    Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
    Braun LH; Baumann D; Zwirner K; Eipper E; Hauth F; Peter A; Zips D; Gani C
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Role of Peripheral Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.
    Ergen ŞA; Barlas C; Yıldırım C; Öksüz DÇ
    J Gastrointest Cancer; 2022 Mar; 53(1):151-160. PubMed ID: 33392960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy.
    Xu J; Ni C; Ma C; Zhang L; Jing X; Li C; Liu Y; Qu X
    Clin Transl Oncol; 2017 Aug; 19(8):989-996. PubMed ID: 28247194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using Soluble Immune Checkpoints.
    Ari A; Sevik H; Sevinc MM; Tatar C; Buyukasik K; Surel AA; Idiz UO
    Cancer Biother Radiopharm; 2024 Apr; 39(3):247-254. PubMed ID: 38010745
    [No Abstract]   [Full Text] [Related]  

  • 16. Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy.
    Kim TG; Park W; Kim H; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Kang KM
    Tumori; 2019 Oct; 105(5):434-440. PubMed ID: 30117371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
    Wang P; Wang Z; Liu Y; Xie J; Ren Y
    Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMPLETE BLOOD COUNT DERIVED INFLAMMATORY BIOMARKERS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES.
    Nanava N; Betaneli M; Giorgobiani G; Chikovani T; Janikashvili N
    Georgian Med News; 2020 May; (302):39-44. PubMed ID: 32672687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Krauthamer M; Rouvinov K; Ariad S; Man S; Walfish S; Pinsk I; Sztarker I; Charkovsky T; Lavrenkov K
    Oncology; 2013; 85(1):27-32. PubMed ID: 23816828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma.
    Sun Y; Huang Z; Chi P
    Int J Clin Oncol; 2020 Jul; 25(7):1299-1307. PubMed ID: 32274615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.